Study to Evaluate Electrocardiographic Effects of Therapeutic & Supratherapeutic Doses of Cytisinicline in Healthy Smokers
Clinical trial NCT05566288 · COMPLETED
Trial details
- NCT number
- NCT05566288
- Sponsor
- Achieve Life Sciences
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-17
- Primary completion
- 2022-12-23
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.